Why the study?
Little is known about protease-nexin 1 expression and its regulation in the vascular system, particularly in hypertension.
Does l-NAME-induced chronic hypertension alter the expression of functional protease-nexin 1 (PN-1) in rat arterial media?
Does l-NAME-induced chronic hypertension alter the expression of functional protease-nexin 1 (PN-1) in rat arterial media?
Protease-nexin 1 is present in rat aortic smooth muscle cells and its functional expression is significantly upregulated during chronic hypertension, suggesting a role in regulating vascular thrombin activity.
Objective— Protease-nexin 1 (PN-1) belongs to the serpin superfamily and behaves as a specific thrombin inhibitor in the pericellular environment. Little is known about PN-1 expression and its regulation in the vascular system. In this study, we examined the expression of functionally active PN-1 in vitro in rat aortic smooth muscle cells and in vivo in rat arterial media and its regulation in hypertensive rats. Methods and Results— The vascular PN-1 formed specific covalent complexes with thrombin involving the catalytic site of the protease, and heparin increased the formation of these complexes. We also demonstrated PN-1 in rat arterial media by immunohistochemical staining. Moreover, we examined in vivo vascular expression of PN-1 in a model of chronic hypertension induced by long-term administration of N G -nitro- l -arginine methyl ester ( l -NAME). Marked increases in PN-1 mRNA (3-fold) and protein (2-fold) were observed after 2 months of hypertension. Increased expression of PN-1 in the vascular wall was associated with an increase in the formation of complexes between radiolabeled-thrombin and PN-1, indicating that PN-1 was functional. Conclusions— PN-1 may thus participate in the mechanisms that regulate thrombin activity in the vessel wall.
No takes yet. Share an insight, caveat, or question.
Bouton et al. (2003) studied Hypertension. Chronic hypertension induced by l-NAME was evaluated on PN-1 mRNA and protein expression (3-fold (mRNA), 2-fold (protein)).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: